We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genome Mining Technique Furthers Biologic Discovery

By LabMedica International staff writers
Posted on 26 Oct 2011
Print article
A newly developed method for microscopically extracting, or “mining,” data from genomes could represent a considerable boost in the search for new therapeutic drugs and improve the understanding of basic functions such as how cells communicate with one another.

Analyzing marine and terrestrial samples obtained from Alaska to San Diego’s La Jolla Cove, a research technique jointly created by scientists from the University of California San Diego (UCSD) Scripps Institution of Oceanography (La Jolla, USA) and Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD (CA, USA) and their colleagues taps powerful laboratory instruments to trace promising chemical compounds back to their genomic roots. The study’s findings were published the October 9, 2011, online publication of the journal Nature Chemical Biology.

Graduate student Roland Kersten developed a technique that utilizes mass spectrometry, a mass-analyzing application that decodes the composition and size of molecules, to reveal core structural features of genomes. “With only very small amounts of crude sample material, the mass spectrometer is able to fragment the unknown peptide into individual amino acid building blocks, so we can then map those to the genome level,” said Dr. Kersten, who works jointly in Dr. Pieter Dorrestein’s laboratory at the School of Pharmacy and Dr. Brad Moore’s lab at the Scripps Center for Marine Biotechnology and Biomedicine. “That provides us information about how to reassemble the molecule.”
Knowing such details through this genomic mining approach gives scientists a way to connect the natural chemicals generated by organisms back to the enzymes that construct them. These biosynthetic pathways are considered very valuable data in the search for new pharmaceuticals to treat diseases.

Using the new method, the scientists have already discovered two new classes of peptides, compounds comprised of amino acids that serve in functions ranging from communication to protection. “This represents a paradigm shift in the way that natural products are discovered and characterized, and it’s fundamentally different than what’s been practiced for the past decades in this field,” said Dr. Moore, a professor at Scripps and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD. “This has the capability of really changing the way natural products, or simply chemicals, are discovered in nature.”

The researchers are working on ways to automate the process to analyze biological samples faster. They believe the new technique will streamline the discovery of promising natural products. “We’re trying to bring up the speed of discovery in chemistry,” said Dr. Moore. “There’s a huge amount of information that’s out there and we are only scratching the surface-we’d like to dig a little deeper.”

“My UC San Diego colleague Bill Gerwick often states that natural products are a part of central dogma following DNA, RNA and proteins,” said Dr. Dorrestein. “I agree with Bill, natural products and related chemistries control biology yet these molecules are difficult to characterize. The tools for characterizing the molecules that control biology have not kept pace with modern science. The thought process introduced in this manuscript provides the foundation for finally bringing the fourth branch of central dogma into the realm of modern life sciences.”

Related Links:
Scripps Institution of Oceanography
Skaggs School of Pharmacy and Pharmaceutical Sciences

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Chlamydia Test Kit
CHLAMYTOP
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.